Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Yervoy
Yervoy
FDA Accepts Bristol-Myers Squibb Co Supplemental Yervoy BLA For Melanoma
Bidness Etc.
Tue, 03/3/15 - 08:32 am
FDA
Yervoy
Bristol-Myers Squibb
melanoma
Merck CEO Frazier credits Keytruda success to slim-down strategy
Fierce Pharma
Tue, 01/13/15 - 10:47 am
Merck
Pharma CEOs
Kenneth Frazier
Keytruda
Yervoy
melanoma
Idera Pharmaceuticals (IDRA) Stock Rises After Cancer Drug Shows Anti-Tumor Activity In Pre-Clinical Study
Bidness Etc.
Wed, 12/3/14 - 08:05 am
Idera Pharmaceuticals
IMO-2055
Yervoy
cancer
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thu, 11/6/14 - 09:03 am
Sovaldi
Gilead Sciences
Eyelea
Tecfidera
Zytiga
Kalydeco
Vertex Pharmaceuticals
Victoza
Novo Nordisk
Gilenya
Yervoy
Xtandi
Stribild
Stelara
Bristol-Myers Squibb's Oncology Opportunity
Motley Fool
Tue, 06/24/14 - 09:11 am
Bristol-Myers Squibb
Yervoy
melanoma
Bristol Shares Sag On Cancer Drug Worries
Forbes
Thu, 06/5/14 - 10:53 pm
Bristol-Myers Squibb
Yervoy
nivolumab
cancer
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Yahoo/Benzinga
Thu, 06/5/14 - 12:04 pm
ASCO
cancer immunotherapy
Bristol-Myers Squibb
Yervoy
Merck
MK-3475
Bristol Defends Data; Roche Shines In Cancer Showdown
Investors.com
Mon, 06/2/14 - 02:51 pm
Roche
Bristol-Myers Squibb
nivolumab
Yervoy
melanoma
MPDL3280A
bladder cancer
ASCO
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
Yahoo/Reuters
Mon, 06/2/14 - 09:42 am
Yervoy
brain cancer
immunotherapy
Bristol-Myers Squibb
ASCO
nivolumab
Immune Therapy’s Cancer Promise Creates Research Rush
Bloomberg
Thu, 05/29/14 - 08:52 am
cancer immunotherapy
Merck
MK-3475
Roche
Yervoy
Bristol-Myers Squibb
Merck KGaA
AstraZeneca
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks
Yahoo/24-7 Wall St
Mon, 03/10/14 - 10:13 am
Eli Lilly
Bristol-Myers Squibb
Merck
Pfizer
Yervoy
palbociclib
animal health
ramucirumab
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment
Marketwatch
Tue, 03/4/14 - 10:21 pm
Bristol-Myers Squibb
Yervoy
lung cancer
Immune Checkpoint Blocker Race Heats Up
Wall St Cheat Sheet
Tue, 02/18/14 - 10:19 am
immune checkpoint blockers
Yervoy
Bristol-Myers Squibb
MK-3475
Merck
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wed, 02/12/14 - 09:14 am
cancer immunotherapy
Merck
Bristol-Myers Squibb
Amgen
Incyte
Pfizer
MK-3475
Ablynx
Yervoy
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
Seeking Alpha
Fri, 01/31/14 - 08:14 am
oncology
immunotherapy
Bristol-Myers Squibb
melanoma
Yervoy
Merck hits a new high as analyst sees opening for new cancer drug
Marketwatch
Mon, 01/27/14 - 12:00 pm
Merck
MK-3475
lung cancer
Bristol-Myers Squibb
Yervoy
Galectin announces IND filed to study GR-MD-02 in combination with Yervoy
Yahoo/Fly on the Wall
Wed, 01/15/14 - 10:08 am
GR-MD-02
Galectin
Yervoy
metastatic melanoma
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Thu, 01/2/14 - 09:35 am
Bristol-Myers Squibb
Roche
brain cancer
CytRx
Celldex Therapeutics
ImmunoCellular Therapeutics
Northwest Biotherapeutics
glioblastoma multiforme
nivolumab
Yervoy
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
Merck Faces Off Against Bristol-Myers' Yervoy
Motley Fool
Mon, 12/2/13 - 05:00 pm
Yervoy
Bristol-Myers Squibb
MK-3475
melanoma
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »